Recommendations for a Canadian Breast Implant Registry

Victoria M S Rea1, Raveena Gowda2, Emma Nicholson2

  • 1Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Introduction: Use of breast implants has nearly doubled for reconstructive and aesthetic surgery throughout North America. This growing demand highlights the need for breast implant registries to monitor safety and quality of care. Despite wide adoption of implant registries in other countries, there is currently no Canadian system to track implantation of breast prostheses. This review aimed to inform the development and implementation of a Canadian breast implant registry (BIR). Methods: A systematic review was conducted to include searches of Medline Ovid, Web of Science, Embase Ovid and grey literature databases. Data were extracted for: patient participation, registry structure, data quality, funding and reporting outputs. Results: Of 1577 articles, a total of 19 met inclusion criteria. The Dutch, Australian, American, German, United Kingdom and Korean implant registries were analyzed. Opt-out systems were commonly used and correlated with higher capture rates. Data input relied on physician or surgeon data entry. Funding was private for the Dutch BIR through a patient or insurance surcharge, and government funding was used in the United Kingdom, Australian and Korean registries. Finally, all registries disseminated outcomes via annual reports. Conclusion: Based on strategies used in existing registries, it is recommended a Canadian BIR have an opt-out structure, funding from a combination of government or private stakeholders, use a standardized data set and annual reporting.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
Good Manufacturing Practices01:26

Good Manufacturing Practices

Good Manufacturing Practices (GMP) constitute a foundational set of guidelines that ensure the production of safe, consistent, and high-quality products, particularly in industries such as pharmaceuticals, biotechnology, and food processing. These protocols encompass all aspects of production, from the sourcing of raw materials to the final distribution of the finished product.A core pillar of GMP is stringent hygiene and sanitation across all production environments. This includes routine...